Search - tctmd.com

Presenter: G. Schymik, T. Herbinger, A. Wuerth, J.-S. Schymik, P. Bramlage, M. Heimeshoff, T. Sueselbeck, R. Kiefer, B.-D. Gonska, H. Posival, C. Schmitt, H. Schroefel

January 31, 2013

Presentation TCT 2013

Successful Transfemoral Implantation of a Medtronic CoreValve in Patients with Severe Aortic Regurgitation: a Single Centre Experience

Presenter: Marco Luciano Rossi, Roberto Bocchi, Paolo Pagnotta, Gabriele Gasparini, Dennis Zavalloni, Patrizia Presbitero

January 31, 2013

Presentation TCT 2013

Effect of Transfemoral Aortic Valve Implantation on Plasma Brain Natriuretic Peptide Levels and Its Predictive Value for 30-day and 1-year survival

Presenter: Karim El Chilali, Thomas Konorza, Fadi Al-Rashid, Polykarpos Christos Patsalis, Bjoern Plicht, Daniel Wendt, Matthias Thielmann, Heinz Jakob, Raimund Erbel, Philipp Kahlert

January 31, 2013

Advertisement

Un Meta Análisis Analiza la Regurgitación Post-TAVR y su Influencia sobre la Mortalidad

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Se reportó infección post-TAVR en 1 de cada 5 pacientes, pero no asociada a la mortalidad

Post-TAVR Infection Reported in 1 of 5 Patients But Not Linked with Mortality

Pequeño estudio apoya TAVR transaórtica como mejor opción que la transapical

Meta-analysis Looks at Post-TAVR Regurgitation, Influence on Mortality

New Data from the PARTNER Non-Randomized Continued Access Registry: Outcomes After Transfemoral Transcatheter Aortic Valve Replacement

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

Myocardial Injury Common with TAVR, Prognostic Only If Accompanied by AKI

La Lesión Miocárdica es Frecuente con la TAVR, el Pronóstico solo puede dares si está Acompañada de LRA

TAVR utilizada contra la Regurgitación Severa Sin Estenosis

TAVR Used for Severe Regurgitation Without Stenosis

St. Jude Medical Announces First Implant Evaluating New Size of Portico Heart Valve in Ongoing European Clinical Trial

Transradial Catheterization is Not Associated With Increased Patient Radiation Exposure Compared to Transfemoral Access: A Meta-analysis

TIMING OF ACCESS SITE BLEEDING AFTER TRANSFEMORAL CORONARY INTERVENTION

TAVR– 3 year results of transapical versus transfemoral approach in a real world population of 1000 patients with severe aortic stenosis

Successful Transfemoral Implantation of a Medtronic CoreValve in Patients with Severe Aortic Regurgitation: a Single Centre Experience

Effect of Transfemoral Aortic Valve Implantation on Plasma Brain Natriuretic Peptide Levels and Its Predictive Value for 30-day and 1-year survival

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content